Effects of Different Antiviral Treatments on Liver Inflammation and Fibrosis in Patients With Chronic Hepatitis B

Documenti analoghi

• Multiple Low‐Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy
  di: Zhengzhao Lu, et al.
  Pubblicazione: (2024)
• M1 ‐Like Macrophage May Contribute to the Inflammation and Fibrosis Process of Chronic Hepatitis B
  di: Yuxue Gao, et al.
  Pubblicazione: (2025)
• Reply: Regarding the Predictive Role of CXCL16 in Liver Inflammation in Chronic Hepatitis B Patients
  di: Yawen Wan, et al.
  Pubblicazione: (2024)
• Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment
  di: Lilian Yan Liang, et al.
  Pubblicazione: (2024)
• Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors
  di: Wesal Elgretli, et al.
  Pubblicazione: (2025)